Discover 1,279 paid clinical trials in Chula Vista, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,279
Active & Responsive
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
for
Lactating Women on Select DOI,
Location: La Jolla CA, Loma Linda CA, Salt Lake City UT,
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT03511118
Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: San Diego CA, La Jolla CA, Tucson AZ, Portland OR,
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
for
Veterans, Tobacco Use Disorder, Cigarette Smoking,
Location: San Diego CA, Minneapolis MN, Durham NC
Sponsor: VA Office of Research and Development
Sex: All
Age: 21+
Code: NCT06966362
Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: La Jolla CA, Newport Beach CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Location: La Jolla CA, Los Angeles CA, Gilbert AZ, Seattle WA,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06682793
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: La Jolla CA, Newport Beach CA, Orange CA, Duarte CA,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase3, Recruiting
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Location: La Jolla CA, Laguna Hills CA, Palm Springs CA,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 0+
Code: NCT04427384
Recruiting
Active & ResponsiveNew
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: La Jolla CA, Irvine CA, Orange CA, Loma Linda CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: La Jolla CA, Los Angeles CA, Gilbert AZ, Stanford CA,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06051695
Phase1, Phase2, Recruiting
Active & Responsive
Multisite Implementation of COMPRENDO
for
Pediatric Cancer
Location: San Diego CA, San Francisco CA, Birmingham AL,
Sponsor: University of California, San Diego
Sex: All
Age: 18+
Code: NCT06055296
Recruiting
Active & Responsive
A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
for
Secondary AML, Myelofibrosis
Location: San Diego CA, Duarte CA, Sacramento CA
Sponsor: Aspera Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07250646
Phase1, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Location: La Jolla CA, Los Angeles CA, Palo Alto CA,
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07326566
Phase2, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: La Jolla CA, Irvine CA, Duarte CA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase1, Phase2, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: San Diego CA, Duarte CA, Beverly Hills CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase3, Recruiting
Active & Responsive
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: La Jolla CA, Cerritos CA, Los Angeles CA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT06901531
Phase3, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: La Jolla CA, San Francisco CA, El Paso TX, Eugene OR,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: La Jolla CA, Irvine CA, Orange CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Location: La Jolla CA, Seattle WA, Dallas TX, Vancouver,
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT05552157
Phase2, Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
for
Rheumatoid Arthritis
Location: La Jolla CA, Upland CA, Los Angeles CA, Peoria AZ,